Cat.#: ASSD-136
| Description | A2A antagonist. Binds irreversibly. Apparent pKi values at A2ARs are 8.27 (after 0.5h) and 8.99 (after 3h), where a Ki shift indicates a covalent mode of action. |
| Size | 50 μg |
| Chemical Name | 4-[3-[[7-Amino-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl]amino]propylcarbamoyl]benzenesulfonyl fluoride |
| Molecular formula | C18H17FN8O4S |
| PubChem identifier | 145958874 |
| Purity | >95% |
| Solubility | Soluble in DMSO |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-194 | 7-(Diethylamino)coumarin-3-carboxylic acid (AC194) | 100 mg | inquiry |
| ASSD-175 | 5-Carboxyfluorescein-N-hydroxysuccinimide Ester (AC175) | 25 mg | inquiry |
| ASSD-196 | 5-Carboxyfluorescein (AC196) | 100 mg, 250 mg | inquiry |
| ASSD-169 | Calcium Ionophore A23187 (AC169) | 1mg, 5mg, 10 mg | inquiry |
| ASSD-142 | Methoxy-X04 (AC142) | 10 mg, 50 mg | inquiry |
| ASSD-225 | Antifade Fluorescence Mounting Medium with Propidium Iodide (aqueous) (AC225) | 10 mL | inquiry |
| ASSD-119 | Fluorescent adenosine agonist [NECA] (AC119) | 500 μg | inquiry |
| ASSD-112 | Propidium Iodide Staining Solution (1mg/ml) in water (AC112) | 1 mL | inquiry |
| ASSD-205 | Acridinium C2 NHS Ester (AC205) | 5 mg, 10 mg | inquiry |
| ASSD-153 | Brilliant Blue G (AC153) | 1g | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.